Introduction
to the Tata Trusts
Know the
work we do
Discover our impact
stories and campaigns
Publications
and reports
In the media
Opportunities
for impact
Knowledge creates its greatest value when it informs action. The Tata Trusts partner with organisations that transform research into evidence that shapes decisions across public systems. Connecting knowledge with policy and practice allows these organisations to help build India's capacity to solve complex problems.
Many of today's challenges demand patient research supported by sustained investment. Through investments in institutional capability and support for independent inquiry, the Trusts enable knowledge organisations to pursue emerging fields that address national priorities while creating solutions that benefit society.
Through SAFER Hills (Augmented Facilities for Empowering Resilience in Himalayan Hills) initiative, the Tata Trusts are partnering with IIT Mandi with a five-year grant running from 2025 to 2030 to strengthen disaster preparedness, community resilience and innovation across the Himalayan region. The Trusts seek to combine science, community insight and institutional capacity into practical solutions for those most exposed to risk.
In 2017, the Tata Trusts convened a group of sectoral experts to develop a report measuring the structural capacity of state justice institutions against their own declared mandates. As a result, the first India Justice Report (IJR) was published in November 2019. The IJR tracks each state's capacity to deliver justice through quantitative measures of budgets, human resources, infrastructure, workload and diversity across police, judiciary, prisons, legal aid and Human Rights Commissions. Vidhi is one of the partner organisations working with the IJR on this report.
In 2015, the Tata Trusts partnered with the Centre for Brain Research (CBR) at IISc Bengaluru to launch the Tata Longitudinal Study of Aging, bringing together volunteers aged 45 and above with no known neurological conditions for multimodal clinical, cognitive and genetic assessment. The goal is to understand the pathogenic mechanism underlying the changes that occur in the preclinical stage of dementia, including Alzheimer's disease, and to identify biomarkers that could support earlier detection, before clinical symptoms appear.
